These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38381951)

  • 21. The impact, cost and cost-effectiveness of oral pre-exposure prophylaxis in sub-Saharan Africa: a scoping review of modelling contributions and way forward.
    Case KK; Gomez GB; Hallett TB
    J Int AIDS Soc; 2019 Sep; 22(9):e25390. PubMed ID: 31538407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluation of HIV pre-exposure prophylaxis strategies: protocol for a methodological systematic review and quantitative synthesis.
    Thavorn K; Kugathasan H; Tan DHS; Moqueet N; Baral SD; Skidmore B; MacFadden D; Simkin A; Mishra S
    Syst Rev; 2018 Mar; 7(1):47. PubMed ID: 29544530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrating Enhanced HIV Pre-exposure Prophylaxis Into a Sexually Transmitted Infection Clinic in Lilongwe: Protocol for a Prospective Cohort Study.
    Rutstein SE; Matoga M; Chen JS; Mathiya E; Ndalama B; Nyirenda N; Bonongwe N; Chithambo S; Chagomerana M; Tegha G; Hosseinipour MC; Herce ME; Jere E; Krysiak RG; Hoffman IF
    JMIR Res Protoc; 2022 Dec; 11(12):e37395. PubMed ID: 36469400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a Mobile App to Increase the Uptake of HIV Pre-exposure Prophylaxis Among Latino Sexual Minority Men: Qualitative Needs Assessment.
    Cantos VD; Hagen K; Duarte AP; Escobar C; Batina I; Orozco H; Rodriguez J; Camacho-Gonzalez A; Siegler AJ
    JMIR Form Res; 2023 Feb; 7():e43844. PubMed ID: 36625855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-Exposure Prophylaxis Care Continuum for HIV Risk Populations: An Umbrella Review of Systematic Reviews and Meta-Analyses.
    Jin G; Shi H; Du J; Guo H; Yuan G; Yang H; Zhu Z; Zhang J; Zhang K; Zhang X; Lu X; Xu W; Wang S; Hao J; Sun Y; Su P; Zhang Z
    AIDS Patient Care STDS; 2023 Dec; 37(12):583-615. PubMed ID: 38011347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers.
    Kayesu I; Mayanja Y; Nakirijja C; Machira YW; Price M; Seeley J; Siu G
    BMC Womens Health; 2022 Nov; 22(1):440. PubMed ID: 36357920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: results of a consultation with community stakeholders.
    Mack N; Odhiambo J; Wong CM; Agot K
    BMC Health Serv Res; 2014 May; 14():231. PubMed ID: 24886646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
    Nyblade L; Ndirangu JW; Speizer IS; Browne FA; Bonner CP; Minnis A; Kline TL; Ahmed K; Howard BN; Cox EN; Rinderle A; Wechsberg WM
    BMC Public Health; 2022 Oct; 22(1):1916. PubMed ID: 36242000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa.
    Muhumuza R; Ssemata AS; Kakande A; Ahmed N; Atujuna M; Nomvuyo M; Bekker LG; Dietrich JJ; Tshabalala G; Hornschuh S; Maluadzi M; Chibanda-Stranix L; Nematadzira T; Weiss HA; Nash S; Fox J; Seeley J
    Arch Sex Behav; 2021 May; 50(4):1729-1742. PubMed ID: 33954824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adolescent-Centered HIV Prevention: Perspectives on Acceptability of Oral Antiretroviral Pre-exposure Prophylaxis for Adolescents in a Global Priority Setting.
    Giovenco D; Kuo C; Underhill K; Hoare J; Operario D
    Arch Sex Behav; 2021 Oct; 50(7):2921-2931. PubMed ID: 34561792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barriers and facilitating factors to the uptake of antiretroviral drugs for prevention of mother-to-child transmission of HIV in sub-Saharan Africa: a systematic review.
    Gourlay A; Birdthistle I; Mburu G; Iorpenda K; Wringe A
    J Int AIDS Soc; 2013 Jul; 16(1):18588. PubMed ID: 23870277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral Pre-exposure Prophylaxis Uptake and Acceptability Among Men Who Have Sex With Men: A Scoping Review of the Literature.
    Moyo PL; Nunu WN
    Am J Mens Health; 2023; 17(5):15579883231201729. PubMed ID: 37776162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Costs and outcomes of routine HIV oral pre-exposure prophylaxis implementation across different service delivery models and key populations in South Africa.
    Hendrickson C; Hirasen K; Mongwenyana C; Benade M; Bothma R; Smith C; Meyer J; Nichols B; Long L
    medRxiv; 2023 Aug; ():. PubMed ID: 37645864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.
    Poteat T; Malik M; van der Merwe LLA; Cloete A; Adams D; Nonyane BAS; Wirtz AL
    Lancet HIV; 2020 Dec; 7(12):e825-e834. PubMed ID: 32622370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender-Specific Combination HIV Prevention for Youth in High-Burden Settings: The MP3 Youth Observational Pilot Study Protocol.
    Buttolph J; Inwani I; Agot K; Cleland CM; Cherutich P; Kiarie JN; Osoti A; Celum CL; Baeten JM; Nduati R; Kinuthia J; Hallett TB; Alsallaq R; Kurth AE
    JMIR Res Protoc; 2017 Mar; 6(3):e22. PubMed ID: 28274904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demand creation and retention strategies for oral pre-exposure prophylaxis for HIV prevention among men who have sex with men and transgender women: a systematic review and meta-analysis.
    Guimarães NS; Magno L; Monteiro GMB; Ramos ICN; de Castro CT; Aranha-Rossi TR; Pereira M; Dourado I
    BMC Infect Dis; 2023 Nov; 23(1):793. PubMed ID: 37964202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study.
    Smith J; Bansi-Matharu L; Cambiano V; Dimitrov D; Bershteyn A; van de Vijver D; Kripke K; Revill P; Boily MC; Meyer-Rath G; Taramusi I; Lundgren JD; van Oosterhout JJ; Kuritzkes D; Schaefer R; Siedner MJ; Schapiro J; Delany-Moretlwe S; Landovitz RJ; Flexner C; Jordan M; Venter F; Radebe M; Ripin D; Jenkins S; Resar D; Amole C; Shahmanesh M; Gupta RK; Raizes E; Johnson C; Inzaule S; Shafer R; Warren M; Stansfield S; Paredes R; Phillips AN;
    Lancet HIV; 2023 Apr; 10(4):e254-e265. PubMed ID: 36642087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Barriers to and enablers of uptake of antiretroviral therapy in integrated HIV and tuberculosis treatment programmes in sub-Saharan Africa: a systematic review and meta-analysis.
    Kadia BM; Dimala CA; Fongwen NT; Smith AD
    AIDS Res Ther; 2021 Nov; 18(1):85. PubMed ID: 34784918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.
    Price JT; Wheeler SB; Stranix-Chibanda L; Hosek SG; Watts DH; Siberry GK; Spiegel HM; Stringer JS; Chi BH
    J Acquir Immune Defic Syndr; 2016 Aug; 72 Suppl 2(Suppl 2):S145-53. PubMed ID: 27355502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers to uptake of community-based health insurance in sub-Saharan Africa: a systematic review.
    Shewamene Z; Tiruneh G; Abraha A; Reshad A; Terefe MM; Shimels T; Lemlemu E; Tilahun D; Wondimtekahu A; Argaw M; Anno A; Abebe F; Kiros M
    Health Policy Plan; 2021 Nov; 36(10):1705-1714. PubMed ID: 34240185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.